Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination.

We used a rodent model of cuprizone-induced demyelination to examine the peripheral benzodiazepine receptor (PBR) response during remyelination. C57BL/6J mice were fed a 0.2% cuprizone-containing or control diet for 3 weeks and then removed to allow for remyelination. Quantitative autoradiography of 3H-(R)-PK11195 binding to PBR in the corpus callosum showed increased levels at 3 weeks of demyelination and gradually decreased as a function of remyelination. PBR levels were associated with the degree of remyelination and activation of microglia and astrocytes. However, the temporal pattern suggests that the PBR signal during the late stages of remyelination was primarily associated with astrocytes. We also used small-animal positron-emission tomography (PET) imaging to determine if this technique could be used to monitor PBR levels in the brain of living mice. The results indicate that 11C-(R)-PK11195 levels are significantly elevated in the mouse brain during cuprizone-induced demyelination and normalize at a time in which remyelination is complete. These findings support the notion that PBR is a sensitive marker for the visualization and quantification of brain injury and recovery. Further, the in vivo imaging of the PBR response is now possible in the living rodent brain.

[1]  Hyun B Choi,et al.  Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum , 2005, Neurobiology of Disease.

[2]  F. Helmchen,et al.  Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.

[3]  M. Baraldi,et al.  Nuclear location-dependent role of peripheral benzodiazepine receptor (PBR) in hepatic tumoral cell lines proliferation. , 2005, Life sciences.

[4]  L. Garcia-Segura,et al.  Ro5‐4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity , 2005, Journal of neuroscience research.

[5]  E. Yoshikawa,et al.  Microglial activation and dopamine terminal loss in early Parkinson's disease , 2005, Annals of neurology.

[6]  Alexander Gerhard,et al.  Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study , 2005, NeuroImage.

[7]  H. Arnett,et al.  Astroglial‐derived lymphotoxin‐α exacerbates inflammation and demyelination, but not remyelination , 2005, Glia.

[8]  M. Diksic,et al.  Chronological study of peripheral benzodiazepine binding sites in the rat brain stab wounds using [3H] PK-11195 as a marker for gliosis , 2005, Acta Neurochirurgica.

[9]  Elizabeth L Sampson,et al.  In vivo detection of microglial activation in frontotemporal dementia , 2004, Annals of neurology.

[10]  G. Glatting,et al.  Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.

[11]  T. Guilarte,et al.  Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. , 2004, Brain : a journal of neurology.

[12]  F. Turkheimer,et al.  Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.

[13]  C. Brosnan,et al.  Quantitative aspects of reactive gliosis: A review , 1992, Neurochemical Research.

[14]  T. Guilarte,et al.  Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity , 2003, Neuroscience.

[15]  R B Banati,et al.  [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.

[16]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis , 2003, Steroids.

[17]  J Versijpt,et al.  PET visualization of microglia in multiple sclerosis patients using [11C]PK11195 , 2003, European journal of neurology.

[18]  J. Ryu,et al.  Inhibition of lipopolysaccharide‐induced cyclooxygenase‐2, tumor necrosis factor‐α and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195 , 2002, Journal of neurochemistry.

[19]  P. Soubrié,et al.  SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair. , 2002, The Journal of pharmacology and experimental therapeutics.

[20]  Abraham Weizman,et al.  PK 11195 attenuates kainic acid‐induced seizures and alterations in peripheral‐type benzodiazepine receptor (PBR) protein components in the rat brain , 2002, Journal of neurochemistry.

[21]  Manjit,et al.  Neurology , 1912, NeuroImage.

[22]  R B Banati,et al.  In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. , 2001, Brain : a journal of neurology.

[23]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[24]  A. Fietta,et al.  Diazepam Stimulates Migration and Phagocytosis of Human Neutrophils: Possible Contribution of Peripheral-Type Benzodiazepine Receptors and Intracellular Calcium , 2001, Pharmacology.

[25]  P. Morell,et al.  The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System , 2001, Brain pathology.

[26]  V. Papadopoulos,et al.  Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis. , 2001, International review of neurobiology.

[27]  V. Papadopoulos,et al.  Pathways of dehydroepiandrosterone formation in rat brain glia , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  P. Ferrara,et al.  Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. , 2000, European journal of pharmacology.

[29]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[30]  R B Banati,et al.  Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.

[31]  R Tomczak,et al.  In vivo imaging of activated microglia using [11 C]PK11195 and positron emission tomography in patients after ischemic stroke , 2000, Neuroreport.

[32]  H. Thierens,et al.  Biodistribution and dosimetry of [123I]iodo-PK 11195: a potential agent for SPET imaging of the peripheral benzodiazepine receptor , 2000, European Journal of Nuclear Medicine.

[33]  M. Schumacher,et al.  Steroid synthesis and metabolism in the nervous system: Trophic and protective effects , 2000, Journal of neurocytology.

[34]  A. Fietta,et al.  Diazepam‐binding inhibitor‐derived peptides induce intracellular calcium changes and modulate human neutrophil function , 2000, Journal of leukocyte biology.

[35]  T. Guilarte,et al.  Cellular and Subcellular Localization of Peripheral Benzodiazepine Receptors After Trimethyltin Neurotoxicity , 2000, Journal of neurochemistry.

[36]  R. Dempsey,et al.  Traumatic Brain Injury Leads to Increased Expression of Peripheral-Type Benzodiazepine Receptors, Neuronal Death, and Activation of Astrocytes and Microglia in Rat Thalamus , 2000, Experimental Neurology.

[37]  W. Streit,et al.  Microglial Response to Brain Injury: A Brief Synopsis , 2000, Toxicologic pathology.

[38]  N. Baumann,et al.  Neurosteroid progesterone is up‐regulated in the brain of jimpy and shiverer mice , 2000, Glia.

[39]  Abraham Weizman,et al.  Enigma of the peripheral benzodiazepine receptor. , 1999, Pharmacological reviews.

[40]  Effect of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide (PK11195), a specific ligand of the peripheral benzodiazepine receptor, on the lipid fluidity of mitochondria in human glioma cells. , 1999, Biochemical pharmacology.

[41]  W. Slikker,et al.  Black-Gold: a simple, high-resolution histochemical label for normal and pathological myelin in brain tissue sections , 1999, Brain Research.

[42]  W. Streit,et al.  Reactive microgliosis , 1999, Progress in Neurobiology.

[43]  T. Guilarte,et al.  Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  V. Papadopoulos,et al.  Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. , 1999, Cancer research.

[45]  M. Schumacher,et al.  Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis , 1999, Brain Research.

[46]  K. Suzuki,et al.  Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice , 1998, Journal of Neuroimmunology.

[47]  Alan C. Evans,et al.  PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis , 1997, Journal of neuroscience research.

[48]  T. Guilarte,et al.  The peripheral benzodiazepine receptor is a sensitive indicator of domoic acid neurotoxicity , 1997, Brain Research.

[49]  V. Papadopoulos,et al.  Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis , 1997, Steroids.

[50]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[51]  D. Schober,et al.  Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[52]  T. Guilarte,et al.  Enhanced expression of peripheral benzodiazepine receptors in trimethyltin-exposed rat brain: a biomarker of neurotoxicity. , 1995, Neurotoxicology.

[53]  C. Balaban,et al.  Trimethyltin-induced neuronal damage in the rat brain: Comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins , 1988, Neuroscience.

[54]  M. Graeber,et al.  Functional plasticity of microglia: A review , 1988, Glia.

[55]  C. Pert,et al.  Benzodiazepine receptor-mediated chemotaxis of human monocytes. , 1985, Science.

[56]  André Syrota,et al.  Synthesis of N‐(11C) methyl, N‐(methyl‐1 propyl), (chloro‐2 phenyl)‐1 isoquinoleine carboxamide‐3 (PK 11195): A new ligand for peripheral benzodiazepine receptors , 1984 .

[57]  C. Braestrup,et al.  Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. , 1977, Proceedings of the National Academy of Sciences of the United States of America.